EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Omalizumab for the Treatment of Multiple Food Allergies

Robert A Wood, Alkis Togias, Scott H Sicherer, Wayne G Shreffler iD, Edwin H Kim, Stacie M Jones, Donald Y M Leung, Brian P Vickery, J Andrew Bird, Jonathan M Spergel, Ahmar Iqbal, Julie Olsson und 27 weitere

New England Journal of Medicine · 07.03.2024 · 390 (10) · 889-899

DOI: 10.1056/nejmoa2312382 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 07.03.2024. Verfasst von Robert A Wood und 38 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore (R.A.W., J.D., K.M.), and the National Institutes of Health…. Hauptthemen laut MEDLINE: Desensitization, Immunologic, Food Hypersensitivity, Omalizumab, Anti-Allergic Agents. Die Arbeit wurde bisher 345-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Desensitization, ImmunologicFood HypersensitivityOmalizumabAnti-Allergic AgentsAdolescentChildHumansInfantAllergensArachisPeanut HypersensitivityChild, PreschoolYoung AdultAdultMiddle AgedAntibodies, Anti-Idiotypic

Substanzen

AllergensOmalizumabAnti-Allergic Agentsanti-IgE antibodiesAntibodies, Anti-Idiotypic

Autor:innen und Institutionen

  • From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore (R.A.W., J.D., K.M.), and the National Institutes of Health (National Institutes of Allergy and Infectious Diseases), Bethesda (A…

ORCID-Profile: Wayne G Shreffler, Christopher Parrish

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Allergy and Infectious Diseases
  • Novartis
  • Genentech

Zitieren

APA

Wood, R. A., Togias, A., Sicherer, S. H., Shreffler, W. G., Kim, E. H., Jones, S. M., Leung, D. Y. M., Vickery, B. P., Bird, J. A., Spergel, J. M., Iqbal, A., Olsson, J., Ligueros-Saylan, M., Uddin, A., Calatroni, A., Huckabee, C. M., Rogers, N. H., Yovetich, N., Dantzer, J., …, & Chinthrajah, R. S. (2024). Omalizumab for the Treatment of Multiple Food Allergies. New England Journal of Medicine, 390(10), 889-899. https://doi.org/10.1056/nejmoa2312382

Vancouver

Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, et al. Omalizumab for the Treatment of Multiple Food Allergies. New England Journal of Medicine. 2024;390(10):889-899. doi:10.1056/nejmoa2312382

BibTeX
@article{Wood2024,
  author = {Wood, Robert A and Togias, Alkis and Sicherer, Scott H and Shreffler, Wayne G and Kim, Edwin H and Jones, Stacie M and Leung, Donald Y M and Vickery, Brian P and Bird, J Andrew and Spergel, Jonathan M and Iqbal, Ahmar and Olsson, Julie and Ligueros-Saylan, Monica and Uddin, Alkaz and Calatroni, Agustin and Huckabee, Charmaine Marquis and Rogers, Nicole H and Yovetich, Nancy and Dantzer, Jennifer and Mudd, Kim and Wang, Julie and Groetch, Marion and Pyle, David and Keet, Corinne A and Kulis, Michael and Sindher, Sayantani B and Long, Andrew and Scurlock, Amy M and Lanser, Bruce J and Lee, Tricia and Parrish, Christopher and Brown-Whitehorn, Terri and Spergel, Amanda K Rudman and Veri, Maria and Hamrah, Sanaz Daneshfar and Brittain, Erica and Poyser, Julian and Wheatley, Lisa M and Chinthrajah, R Sharon},
  title = {Omalizumab for the Treatment of Multiple Food Allergies},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {10},
  pages = {889--899},
  doi = {10.1056/nejmoa2312382}
}
Kostenlos starten →